Read + Share
Amedeo Smart
Independent Medical Education
Shah P, Sands J, Normanno N. The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC. Lung Cancer 2021;160:118-126.PMID: 34500194
Email
LinkedIn
Facebook
Twitter
Privacy Policy